欢迎访问云南西力生物技术股份有限公司!证券代码:871574
首页 成 果 源于西力产品的客户论文
Martynoside rescues 5-flfluorouracil-impaired ribosome biogenesis by stabilizing RPL27A. Sci. Bull., 2023, 68: 1662-1677.
发布时间:2023-09-08 阅读数:638 来源:原创
分享到:

Abstract:

Martynoside (MAR), a bioactive component in several well-known tonic traditional Chinese herbs, exhibits pro-hematopoietic activity during 5-flfluorouracil (5-FU) treatment. However, the molecular target and the mechanism of MAR are poorly understood. Here, by adopting the mRNA display with a library of even-distribution (md-LED) method, we systematically examined MAR-protein interactions in vitro and identifified the ribosomal protein L27a (RPL27A) as a key cellular target of MAR. Structural and mutational analysis confifirmed the specifific interaction between MAR and the exon 4,5-encoded region of RPL27A. MAR attenuated 5-FU-induced cytotoxicity in bone marrow nucleated cells, increased RPL27A protein stability, and reduced the ubiquitination of RPL27A at lys92 (K92) and lys94 (K94). Disruption of MAR binding at key residues of RPL27A completely abolished the MAR-induced stabilization. Furthermore, by integrating label-free quantitative ubiquitination proteomics, transcriptomics, and ribosome function assays, we revealed that MAR restored RPL27A protein levels and thus rescued ribosome biogenesis impaired by 5-FU. Specififically, MAR increased mature ribosomal RNA (rRNA) abundance, pre[1]vented ribosomal protein degradation, facilitated ribosome assembly, and maintained nucleolar integrity. Collectively, our fifindings characterize the target of a component of Chinese medicine, reveal the importance of ribosome biogenesis in hematopoiesis, and open up a new direction for improving hematopoiesis by targeting RPL27A.



上一篇:
ewm.jpg 微信公众号
11.jpg 移动官网
特别声明:禁止在未经同意情况下转载本网站信息,BioBioPha品牌产品均由西力生物独家生产与销售,仅用于科学研究或企业研发!
版权所有 2019-2024 云南西力生物技术股份有限公司 BioBioPha 滇ICP备09000810号-1滇公安备案号 53019002000069号
技术支持:奥远科技

联系客服